Physicians have launched the world’s first mRNA lung cancer vaccine trial, marking a significant advancement in cancer treatment.
BioNTech developed the vaccine BNT116, which targets non-small cell lung cancer (NSCLC) by training the immune system to identify and attack tumor markers.
Conducted across seven countries, including Türkiye, the phase 1 trial involves 130 patients with varying stages of lung cancer and aims to eliminate cancer cells and prevent recurrence.
The trial uses mRNA technology similar to that in COVID-19 vaccines, potentially offering a less toxic alternative to traditional chemotherapy.
Experts view this trial as a groundbreaking step in cancer research, with the first patient in the UK receiving the vaccine recently.
Source : PhilNews24 | August 24, 2024
WORLD’S INITIAL LUNG CANCER VACCINE TRIAL KICKS OFF
You might be interested in
Latest from News
President Ferdinand Marcos Jr. has signed Republic Act 12312, officially banning Philippine offshore gaming operators (POGOs)
The Metropolitan Manila Development Authority (MMDA) announced it will suspend the number coding scheme on October
The Bureau of Immigration (BI) announced it will hire additional officers ahead of the Christmas and
The Philippine National Police (PNP) announced it will investigate violations of President Marcos Jr.’s price freeze
The Philippine Conference on Women, Peace, and Security (WPS) kicked off on October 28 at the